首页> 外国专利> RE-IIBP RNF20 Method for screening therapeutic agents of hematological malignancies by interaction RE-IIBP with RNF20

RE-IIBP RNF20 Method for screening therapeutic agents of hematological malignancies by interaction RE-IIBP with RNF20

机译:RE-IIBP RNF20通过RE-IIBP与RNF20相互作用筛选血液系统恶性肿瘤治疗剂的方法

摘要

The present invention is a RE-IIBP and RNF20 binding relates to a blood cancer screening method using the same, particularly to provide a blood cancer screening method comprises the step of screening the candidate drugs to promote bonding RE-IIBP and RNF20. On the other hand, the present inventors have determined that an increase in the degree hayeoteumeuro coupled RE-IIBP and RNF20 increase H3K79 HMTase activity of the RE-IIBP and, by stimulating the RE-IIBP- mediated transfer MEIS1 increase blood cancer cell death, the RE-IIBP and when combined RNF20 degree increase may be useful as a blood cancer screening method that increases the number of blood cancer cell death to treat blood cancers.;
机译:本发明是一种RE-IIBP与RNF20的结合,涉及一种使用其的血液癌筛查方法,特别是提供一种血液癌的筛查方法,其包括筛选候选药物以促进RE-IIBP与RNF20结合的步骤。另一方面,本发明人已经确定,Hayeoteumeuro偶联RE-IIBP和RNF20的程度增加会增加RE-IIBP的H3K79 HMTase活性,并通过刺激RE-IIBP介导的转移MEIS1来增加血液癌细胞死亡, RE-IIBP以及联合使用RNF20度增加可作为一种血液癌症筛查方法,可增加血液癌细胞死亡数以治疗血液癌症。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号